Martin Shkreli Overview

  • Investor Type
  • Angel

  • Investments
  • 1

  • Portfolio
  • 1

Martin Shkreli General Information


Mr. Martin Shkreli is a Co-Founder of Druglike. He served as Chief Executive Officer & Chairman at KaloBios Pharmaceuticals. Shkreli is the Founder of Turing Pharmaceuticals and served as its Chief Executive Officer until his resignation from the position due charges of securities fraud in December, 2015. He was previously the Founder and CEO of Retrophin, Inc. (Nasdaq: RTRX), a biotechnology company that develops treatments for rare and catastrophic diseases. Prior to that, Mr. Shkreli was a Managing Member of MSMB Capital, a New York-based hedge-fund and private-equity firm focused on health care investments. Mr. Shkreli has spent his career in the hedge-fund industry, previously in roles with Intrepid Capital Management and Cramer Berkowitz & Co. Mr. Shkreli lives in New York City and received a BBA in Finance from Baruch College.

Contact Information

Primary Investor Type
Angel (individual)
Primary Office
  • 575 Fifth Avenue
  • 14th Floor, 16-118
  • New York, NY 10017
  • United States

Martin Shkreli Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Perlara 01-Apr-2015 00000 00000 00.00 Drug Discovery Generating Revenue 000000 0000000

Martin Shkreli Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Martin Shkreli Team (1)

Name Title Deals Funds Boards Office
Martin Shkreli Angel Investor 0 0 Short Hills, NJ